[Edaily Reporter Kim Hyun-ah ] KTCorporation(030200)will assign popular mobile phone numbers—such as “7777,” “1004,” and “1234”—through a lottery.
KTCorporation announced on the 9th that it will hold a lottery event for “gold numbers.” Gold numbers refer to the last four digits of a mobile phone number that are popular because they are easy to remember or have special meaning. Representative examples include “7777” (repeating the same number), “1234” (consecutive numbers), and “1004” (which means “angel”).
A total of 10,000 numbers will be available in this drawing. The gold numbers released by KTCorporation consist of 155 different types, including those with four repeating digits, consecutive numbers, and numbers with specific meanings.
Applications can be submitted starting November 16 via KT.com, the MyKT app, and KTCorporation stores nationwide. Each person may apply for up to three numbers, and even those who are not KTCorporation subscribers—including users of other carriers or MVNOs—are eligible to participate.
Winners will be announced on December 11. KTCorporation plans to send individual text messages to winners, and results will also be available on the KTCorporation website and the MyKTCorporation app. Winning numbers must be registered at a KTCorporation store or on KTCorporation.com by December 31.
Because gold numbers are in high demand, telecom carriers allocate them through a lottery. This is intended to prevent number trading or monopolization and to provide users with a fair opportunity to obtain them.
#Xcell Therapeutics Inc. is pursuing a third-party private placement worth 7 to 8 billion won to avoid the risk of negative equity by year-end. This comes after the company raised funds through a 9.5 …
Kim Dong-seon, President of Future Strategy at #Hanwha Machinery & Service Holdings (Hanwha M&S), is launching an additional tender offer for Hanwha M&S shares, investing approximately 27 billion won.…
Celltrion CI (Photo courtesy of Celltrion)
Celltrion ( Celltrion(068270)) is seeking to expand the indication for its autoimmune disease treatment “Stekima” (active ingredient: ustekinumab) to inc…